Taking into account the recent acquisition of Nevro, the net sales for the fiscal year 2025 are projected to be between $2.80 billion and $2.90 billion, with net EPS estimated to be in the range of $3 ...

Taking into account the recent acquisition of Nevro, the net sales for the fiscal year 2025 are projected to be between $2.80 billion and $2.90 billion, with net EPS estimated to be in the range ...

NEWTOWN, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations at Nevro Corp. (“Nevro”).

考虑到最近收购Nevro，2025财年净销售额预计将在28亿美元至29亿美元之间，净每股收益估计在$3.10至$3.40范围内。该公司展示了强劲增长，过去十二个月收入增长60.62%。InvestingPro分析揭示了关于Globus Medical增长前景和财务健康的8项额外关键见解。 在最近的一次会议 ...

StockNews.com started coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the treatment ...

On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s possession was subject to unauthorized access.